Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with huntington disease(293 views visite) Esmaeilzadeh M, Kullingsjo J, Ullman H, Varrone A, Tedroff J
Keywords Parole chiave: Acr16, Brain Metabolism, Fdg Pet Imaging, Huntington Disease, Pridopidine, Fluorodeoxyglucose F 18, Adult, Article, Brain Region, Clinical Article, Clinical Assessment, Drug Dose Increase, Drug Safety, Drug Tolerability, Female, Glucose Brain Level, Glucose Metabolism, Human, Huntington Chorea, Metabolic Rate, Open Study, Positron Emission Tomography, Precuneus, Priority Journal, Rating Scale, Thalamus Dorsomedial Nucleus, Energy Metabolism, Middle Aged, Piperidines, Positron-Emission Tomography, Treatment Outcome,
Affiliations Affiliazioni: *** IBB - CNR ***
Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital, Stockholm, SE-17176, Sweden NeuroSearch Sweden AB, Stockholm, Sweden
References Riferimenti: Walker, F.O., Huntington's disease (2007) Lancet, 369 (9557), pp. 218-228. , DOI 10.1016/S0140-6736(07)60111-1, PII S014067360760111
Folstein, S., (1989) Huntington's Disease: A Disorder of Families, , Baltimore, MD: Johns Hopkins University Press
Albin, R.L., Selective neurodegeneration in Huntington's disease (1995) Annals of Neurology, 38 (6), pp. 835-836. , DOI 10.1002/ana.410380602
Gutekunst, C., Norflus, F., Hersch, S., The neuropathology of Huntington's disease (2002) Huntington's Disease, pp. 251-275. , Bates G, Harper P, Jones L, eds, New York, NY: Oxford University Press
Rosas, H.D., Hevelone, N.D., Zaleta, A.K., Greve, D.N., Salat, D.H., Fischl, B., Regional cortical thinning in preclinical Huntington disease and its relationship to cognition (2005) Neurology, 65 (5), pp. 745-747. , DOI 10.1212/01.wnl.0000174432.87383.87
Jueptner, M., Weiller, C., Review: Does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI (1995) Neuroimage, 2, pp. 148-156
Eidelberg, D., Moeller, J.R., Kazumata, K., Antonini, A., Sterio, D., Dhawan, V., Spetsieris, P., Beric, A., Metabolic correlates of pallidal neuronal activity in Parkinson's disease (1997) Brain, 120 (8), pp. 1315-1324. , DOI 10.1093/brain/120.8.1315
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M., Eidelberg, D., Metabolic brain networks associated with cognitive function in Parkinson's disease (2007) NeuroImage, 34 (2), pp. 714-723. , DOI 10.1016/j.neuroimage.2006.09.003, PII S1053811906009323
Feigin, A., Leenders, K.L., Moeller, J.R., Missimer, J., Kuenig, G., Spetsieris, P., Antonini, A., Eidelberg, D., Metabolic network abnormalities in early Huntington's disease: An [ 18F]FDG PET study (2001) Journal of Nuclear Medicine, 42 (11), pp. 1591-1595
Feigin, A., Tang, C., Ma, Y., Mattis, P., Zgaljardic, D., Guttman, M., Paulsen, J.S., Eidelberg, D., Thalamic metabolism and symptom onset in preclinical Huntington's disease (2007) Brain, 130 (11), pp. 2858-2867. , DOI 10.1093/brain/awm217
Dyhring, T., Nielsen, Eÿ., Sonesson, C., The dopaminergic stabilizers pridopidine (ACR16) and (j)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties (2010) Eur. J. Pharmacol., 628, pp. 19-26
Ponten, H., Kullingsjö, J., Lagerkvist, S., In vivo pharmacology of the dopaminergic stabilizer pridopidine (2010) Eur. J. Pharmacol., 644, pp. 88-95
Lundin, A., Dietrichs, E., Haghighi, S., Efficacy and safety of the dopaminergic stabilizer pridopidine (ACR16) in patients with Huntington's disease (2010) Clin. Neuropharmacol, 33, pp. 260-264
De Yebenes, J., Landwehrmeyer, B., Reilmann, R., Pridopidine improves motor function in patients with Huntington's disease-results from the phase 3 multinational European multicenter ACR16 study in Huntington's disease (MermaiHD) (2010) 14th International Congress of Parkinson's Disease and Movement Disorders, , Buenos Aires
Unified Huntington's disease rating scale: Reliability and consistency (1996) Mov. Disord., 11, p. 136. , Huntington Study Group
Wienhard, K., Dahlbom, M., Eriksson, L., Michel, C., Bruckbauer, T., Pietrzyk, U., Heiss, W.-D., The ECAT EXACT HR: Performance of a new high resolution positron scanner (1994) Journal of Computer Assisted Tomography, 18 (1), pp. 110-118
Roland, P.E., Zilles, K., Brain atlases - A new research tool (1994) Trends in Neurosciences, 17 (11), pp. 458-467. , DOI 10.1016/0166-2236(94)90131-7
Esmaeilzadeh, M., Farde, L., Karlsson, P., Extrastriatal dopamine D2 receptor binding in Huntington's disease Hum. Brain Mapp., , in press
Rhodes, C.G., Wise, R.J.S., Gibbs, J.M., In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas (1983) Annals of Neurology, 14 (6), pp. 614-626
Takikawa, S., Dhawan, V., Spetsieris, P., Robeson, W., Chaly, T., Dahl, R., Margouleff, D., Eidelberg, D., Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve (1993) Radiology, 188 (1), pp. 131-136
Talairach, J., Tournoux, P., (1988) Co-planar Stereotaxic Atlas of the Human Brain, , New York, NY: Thieme Medical
Lancaster, J.L., Tordesillas-Gutierrez, D., Martinez, M., Salinas, F., Evans, A., Zilles, K., Mazziotta, J.C., Fox, P.T., Bias between MNI and talairach coordinates analyzed using the ICBM-152 brain template (2007) Human Brain Mapping, 28 (11), pp. 1194-1205. , DOI 10.1002/hbm.20345
Pearson, K., On lines and planes of closest fit to systems of points in space (1901) Philosophical Magazine, 2, pp. 559-572
Eriksson, L., Johansson, E., Kettaneh-Wold, N., Multi-and megavariate data analysis (2006) PCA. Basic Principles and Applications, , Umeå, Sweden: Umetrics AB
Wold, S., Cross-validatory estimation of the number of components in factor and principal component models (1978) Technometrics, 20, pp. 397-405
Jackson, J.E., (1991) A User's Guide to Principle Components, , New York, NY: John Wiley and Sons
Hotelling, H., The generalization of Student's ratio (1931) Ann. Math. Stat., 2, pp. 360-378
Antonini, A., Leenders, K.L., Spiegel, R., Meier, D., Vontobel, P., Weigell-Weber, M., Sanchez-Pernaute, R., Maguire, R.P., Striatal glucose metabolism and dopamine D 2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease (1996) Brain, 119 (6), pp. 2085-2095. , DOI 10.1093/brain/119.6.2085
Georgiou-Karistianis, N., Sritharan, A., Farrow, M., Cunnington, R., Stout, J., Bradshaw, J., Churchyard, A., Egan, G., Increased cortical recruitment in Huntington's disease using a Simon task (2007) Neuropsychologia, 45 (8), pp. 1791-1800. , DOI 10.1016/j.neuropsychologia.2006.12.023, PII S002839320700005X
Kim, J.-S., Reading, S.A.J., Brashers-Krug, T., Calhoun, V.D., Ross, C.A., Pearlson, G.D., Functional MRI study of a serial reaction time task in Huntington's disease (2004) Psychiatry Research - Neuroimaging, 131 (1), pp. 23-30. , DOI 10.1016/j.pscychresns.2004.03.002, PII S0925492704000277
Feigin, A., Ghilardi, M.-F., Huang, C., Ma, Y., Carbon, M., Guttman, M., Paulsen, J.S., Eidelberg, D., Preclinical Huntington's disease: Compensatory brain responses during learning (2006) Annals of Neurology, 59 (1), pp. 53-59. , DOI 10.1002/ana.20684
Walker, F. O., Huntington's disease (2007) Lancet, 369 (9557), pp. 218-228. , DOI 10. 1016/S0140-6736 (07) 60111-1, PII S014067360760111
Albin, R. L., Selective neurodegeneration in Huntington's disease (1995) Annals of Neurology, 38 (6), pp. 835-836. , DOI 10. 1002/ana. 410380602
Rosas, H. D., Hevelone, N. D., Zaleta, A. K., Greve, D. N., Salat, D. H., Fischl, B., Regional cortical thinning in preclinical Huntington disease and its relationship to cognition (2005) Neurology, 65 (5), pp. 745-747. , DOI 10. 1212/01. wnl. 0000174432. 87383. 87
Roland, P. E., Zilles, K., Brain atlases - A new research tool (1994) Trends in Neurosciences, 17 (11), pp. 458-467. , DOI 10. 1016/0166-2236 (94) 90131-7
Rhodes, C. G., Wise, R. J. S., Gibbs, J. M., In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas (1983) Annals of Neurology, 14 (6), pp. 614-626
Lancaster, J. L., Tordesillas-Gutierrez, D., Martinez, M., Salinas, F., Evans, A., Zilles, K., Mazziotta, J. C., Fox, P. T., Bias between MNI and talairach coordinates analyzed using the ICBM-152 brain template (2007) Human Brain Mapping, 28 (11), pp. 1194-1205. , DOI 10. 1002/hbm. 20345
Jackson, J. E., (1991) A User's Guide to Principle Components, , New York, NY: John Wiley and Sons
Kim, J. -S., Reading, S. A. J., Brashers-Krug, T., Calhoun, V. D., Ross, C. A., Pearlson, G. D., Functional MRI study of a serial reaction time task in Huntington's disease (2004) Psychiatry Research - Neuroimaging, 131 (1), pp. 23-30. , DOI 10. 1016/j. pscychresns. 2004. 03. 002, PII S0925492704000277
Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with huntington disease
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(191 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(277 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(402 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(220 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(388 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote